ArticleDevelopment (Cambridge, England)2026
Nr2f1a and Isl1 repress acquisition of epicardial identity in venous atrial cardiomyocytes.
Article in Development (Cambridge, England), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Regulatory networks that maintain cardiomyocyte identity are not completely understood. Here, we have examined the relationship of the transcription factors Nr2f1a and Isl1, which, respectively, repress and promote pacemaker cardiomyocyte (PC) differentiation within the venous pole of zebrafish atria. Using zebrafish nr2f1a;isl1 mutants, we found that loss of Isl1 exacerbates the inability to maintain the atrial cardiomyocyte (AC) identity found in nr2f1a mutant hearts. Subsequently, while nr2f1a;isl1 mutants have a failure of PC differentiation and their ACs are unable to transdifferentiate into PC identity, ACs in nr2f1a;isl1 mutant hearts lose myocardial marker expression, gain epicardial cell (EC) gene expression and exit the myocardial layer. Single-cell RNA-sequencing analysis of hearts supports the observation that the ACs and ECs of nr2f1a;isl1 mutant embryos share common myocardial and EC transcriptomic signatures. Depletion of tcf21 and tbx18 in nr2f1a;isl1 mutants was sufficient to prevent the acquisition of EC identity within putatively transdifferentiating ACs. Thus, our results reveal reiterative requirements for Nr2f and Isl1 transcription factors in binary fate decisions within the genetic hierarchy that maintains distinct AC, PC and EC identities at the venous pole of vertebrate hearts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.